There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Background
This presentation shows how, at the City Hospital, it was possible to improve the
quality of clinical practice in surgery departments and ICUs.
Introduction
Antibiotics play an important role in clinical practice. The expenditure on these
drugs is more than 50% of the total expenditure for drugs at the hospital. Uncontrolled
use of antibiotics, in the environment of intolerably poor financing of the hospitals
in Russia, and the absence of adequate control of the antibiotic prescriptions induce
the growth of resistance in the hospital microbial flora, and as a result the expenditure
on drug treatment increases.
Methodology
An analysis of the antibiotics purchased by the administration of the hospital was
made in order to determine the baseline proportions of the different classes of antibiotics
in the total structure in the year 2003. The analysis showed a high percentage of
beta-lactams in the structure of the antibiotics purchased (88%). The data from the
Diagnostic Laboratory Center of the city were impressive: the level of Klebsiella
pneumoniae producing the enlarged-spectrum beta-lactamases reached a level of 92.5%
in the ICU. An analysis of patients' data at the ICU and surgical departments (in
a cohort of 300) was made in order to evaluate the quality and appropriateness of
the antibiotic prescriptions. An inappropriate choice of antibiotics, wrong dosage,
or an incorrect timing regime were revealed in 60% of cases. The protocols of antibiotic
prophylaxis and the strict rules of antibiotic prescriptions in the ICU, prepared
according to the data of evidence-based medicine, were implemented.
Conclusion
The system of governance of antibiotic prescriptions, the monitoring of the microbial
resistance in the ICU, and the strict adherence to the protocols of antibiotic usage
have gained approval and enabled an improvement in the quality of treatment (from
60% to 30%) and a reduction of the expenditure for antibiotics (40%).